Company intelligence / Profile preview

1099 BioServices

Ownership: Private
Development stage: Other

Overview

1099 BioServices is an active US-based consulting firm serving the biotechnology and biopharmaceutical sectors. It does not develop its own therapeutics or diagnostics but instead offers expertise and support services tailored to life sciences companies. No evidence was found of clinical-stage assets, manufacturing capabilities, or proprietary technology platforms. The company's name references the "1099" tax form commonly associated with independent contractors in the US—a nod to its likely business model as a provider of flexible expert resources for biotech/pharma clients.

Industry: Consulting

Partnerships

Not specified; likely works with various biotech and biopharma clients on a consulting basis.

Beyond the preview

Go deeper on 1099 BioServices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1099 BioServices.

Explore the full profile